Cannabix Technologies Inc. (BLO.CN)
CAD 0.62
(3.23%)
CAD 0.62
(3.23%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -2.95 Million CAD | -49.94% |
| 2022 | -1.97 Million CAD | 41.34% |
| 2021 | -3.11 Million CAD | 63.73% |
| 2020 | -9.1 Million CAD | -193.75% |
| 2019 | -6.94 Million CAD | 20.91% |
| 2018 | -3.83 Million CAD | -174.8% |
| 2017 | -1.34 Million CAD | 61.11% |
| 2016 | -3.53 Million CAD | -275.93% |
| 2015 | -964.63 Thousand CAD | 43.88% |
| 2014 | -1.77 Million CAD | -639.37% |
| 2013 | -239.69 Thousand CAD | -206.19% |
| 2012 | -78.28 Thousand CAD | 64.43% |
| 2011 | -220.07 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -1.2 Million CAD | -25.72% |
| 2023 Q4 | -974.36 Thousand CAD | -115.79% |
| 2023 Q3 | -451.54 Thousand CAD | 52.3% |
| 2023 FY | - CAD | -59.35% |
| 2023 Q1 | -532.99 Thousand CAD | -539.05% |
| 2023 Q2 | -946.68 Thousand CAD | -77.62% |
| 2022 Q3 | -722.73 Thousand CAD | -20.94% |
| 2022 Q1 | -571.4 Thousand CAD | 10.9% |
| 2022 Q4 | -83.4 Thousand CAD | 88.46% |
| 2022 Q2 | -597.6 Thousand CAD | -4.59% |
| 2022 FY | - CAD | 41.34% |
| 2021 Q1 | -537.45 Thousand CAD | 92.45% |
| 2021 Q3 | -1.59 Million CAD | -166.99% |
| 2021 Q4 | -641.29 Thousand CAD | 59.72% |
| 2021 FY | - CAD | 63.73% |
| 2021 Q2 | -596.33 Thousand CAD | -10.96% |
| 2020 Q4 | -7.12 Million CAD | -1130.01% |
| 2020 Q3 | -578.95 Thousand CAD | -20.72% |
| 2020 FY | - CAD | -193.75% |
| 2020 Q2 | -479.59 Thousand CAD | 56.58% |
| 2020 Q1 | -1.1 Million CAD | -63.34% |
| 2019 FY | - CAD | 20.91% |
| 2019 Q3 | -518.08 Thousand CAD | 63.84% |
| 2019 Q1 | -533.07 Thousand CAD | 40.73% |
| 2019 Q2 | -1.43 Million CAD | -168.74% |
| 2019 Q4 | -676.25 Thousand CAD | -30.53% |
| 2018 Q2 | -2.27 Million CAD | -644.29% |
| 2018 FY | - CAD | -174.8% |
| 2018 Q4 | -899.44 Thousand CAD | -73.29% |
| 2018 Q3 | -519.05 Thousand CAD | 77.16% |
| 2018 Q1 | -305.3 Thousand CAD | 36.04% |
| 2017 FY | - CAD | 61.11% |
| 2017 Q3 | -336.65 Thousand CAD | 6.66% |
| 2017 Q4 | -477.32 Thousand CAD | -41.79% |
| 2017 Q1 | -296.67 Thousand CAD | 75.67% |
| 2017 Q2 | -360.68 Thousand CAD | -21.58% |
| 2016 Q1 | -796.06 Thousand CAD | -108.74% |
| 2016 FY | - CAD | -275.93% |
| 2016 Q4 | -1.21 Million CAD | 18.67% |
| 2016 Q2 | -227.94 Thousand CAD | 71.37% |
| 2016 Q3 | -1.49 Million CAD | -557.64% |
| 2015 Q4 | -381.35 Thousand CAD | -74.15% |
| 2015 FY | - CAD | 43.88% |
| 2015 Q3 | -218.98 Thousand CAD | -8.56% |
| 2015 Q2 | -201.71 Thousand CAD | -12.27% |
| 2015 Q1 | -179.66 Thousand CAD | 72.36% |
| 2014 Q2 | -190.03 Thousand CAD | 71.17% |
| 2014 Q3 | -273.02 Thousand CAD | -43.67% |
| 2014 FY | - CAD | -639.37% |
| 2014 Q1 | -659.23 Thousand CAD | -272.25% |
| 2014 Q4 | -649.96 Thousand CAD | -138.06% |
| 2013 FY | - CAD | -206.19% |
| 2013 Q3 | -107.27 Thousand CAD | -58.31% |
| 2013 Q2 | -67.76 Thousand CAD | -249.06% |
| 2013 Q1 | -19.41 Thousand CAD | 66.14% |
| 2013 Q4 | -177.09 Thousand CAD | -65.08% |
| 2012 Q2 | -8359.00 CAD | -4.95% |
| 2012 Q1 | -7965.00 CAD | 0.0% |
| 2012 FY | - CAD | 64.43% |
| 2012 Q4 | -57.33 Thousand CAD | -1141.1% |
| 2012 Q3 | -4620.00 CAD | 44.73% |
| 2011 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aquarius Surgical Technologies Inc. | -456.62 Thousand CAD | -546.252% |
| Predictmedix Inc. | -1.81 Million CAD | -62.423% |